Drug Profile
L-arginine inhalation - PARI
Latest Information Update: 21 Nov 2021
Price :
$50
*
At a glance
- Originator PARI
- Class Basic amino acids; Diamino amino acids; Essential amino acids
- Mechanism of Action Nitric oxide synthase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cystic fibrosis
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Cystic-fibrosis in USA (Inhalation, Aerosol)
- 01 Dec 2006 Clinical trials in Cystic fibrosis in USA (Inhalation)